LifeVantage (LFVN) investor relations material

Executive summary

• Q1 FY2027 revenue fell 22.0% YoY to $37.1M from $47.6M; active accounts declined 19.0% to 98,000, and net loss was $0.2M.

• Adjusted EBITDA was $1.9M, or 5.2% of revenue, versus $3.9M, or 8.2%, a year earlier.

• Priorities include a differentiated brand, simpler digital consumer proposition, more focused operating model, and stronger consumer and advocate community.

Financial highlights

• Gross profit was $28.0M versus $37.8M; operating loss was $0.1M versus $2.3M operating income.

• GAAP net loss was $0.2M, or $0.02 diluted EPS, versus net income of $2.2M, or $0.17; adjusted net income was $0.6M versus $2.3M.

• Adjusted operating income was $0.9M versus $2.5M; adjusted EPS was $0.05 versus $0.18.

• Operating cash flow was positive $0.5M versus cash used of $2.3M.

Outlook and guidance

• Formal guidance was not issued amid the CEO transition and fiscal-year change; the six-month transition period ends December 31, 2026, and the new fiscal year begins January 1, 2027.

• Cash and ongoing operating cash flow were expected to cover requirements for at least 12 months; spending and expenses could be reduced if needed.

• North America website and digital platform launch is planned for Q2 calendar 2027, seller business suite for Q3 2027, with AI tools envisioned 12–18 months out.

• CapEx is expected near $1M per quarter for the next couple of quarters, then taper; annualized spending is expected at $3M–$3.5M for platform and business-suite development.

• Commissions and incentives are expected to settle at 41%–42% of revenue for the full year.